PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Dermatology, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.\', \'Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran.\', \'Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/dth.13733
?:doi
?:hasPublicationType
?:journal
  • Dermatologic therapy
is ?:pmid of
?:pmid
?:pmid
  • 32473070
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.625
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32473070>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32473070>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all